Now, we know that EPO-EPOR signaling is active in a variety of solid tumors [33], that EPO-EPOR expression is particularly increased in hypoxic regions [36] and can influence cancer resistance to pharmacological treatments [29,37]. The gene discussed is EPOR; the disease is cancer.